A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis. Fox EJ, Sullivan HC, Gazda SK, Mayer L, O'Donnell L, Melia K, Lake SL Eur J Neurol. 2012 Feb; 19(2):307-11. Epub 2011 Sep 07. PMID: 21899662. Abstract CommentRecommendBookmarkWatch